Evidence map›Paper›PMID 19370313›Full record

ArticleJournal of computer-aided molecular design2009

Homology modeling and molecular dynamics simulation of N-myristoyltransferase from protozoan parasites: active site characterization and insights into rational inhibitor design.

Chunquan Sheng, Haitao Ji, Zhenyuan Miao, Xiaoyin Che, Jianzhong Yao, Wenya Wang, Guoqiang Dong, Wei Guo, Jiaguo Lü, Wannian Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of computer-aided molecular design, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Research in pharmaceutical sciences · 2026
    Article
  2. Molecules (Basel, Switzerland) · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. State of the art in African trypanosome drug discovery.Current topics in medicinal chemistry · 2011
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Chunquan ShengSchool of Pharmacy, Military Key Laboratory of Medicinal Chemistry, Second Military Medical University, Shanghai, People's Republic of China.
Haitao Ji
Zhenyuan Miao
Xiaoyin Che
Jianzhong Yao
Wenya Wang
Guoqiang Dong
Wei Guo
Jiaguo Lü
Wannian Zhang
Second Military Medical University · CNNorthwestern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myristoyl-CoA:protein N-myristoyltransferase (NMT) is a cytosolic monomeric enzyme that catalyzes the transfer of the myristoyl group from myristoyl-CoA to the N-terminal glycine of a number of eukaryotic cellular and viral proteins. Recent experimental data suggest NMT from parasites could be a promising new target for the design of novel antiparasitic agents with new mode of action. However, the active site topology and inhibitor specificity of these enzymes remain unclear. In this study, three-dimensional models of NMT from Plasmodium falciparum (PfNMT), Leishmania major (LmNMT) and Trypanosoma brucei (TbNMT) were constructed on the basis of the crystal structures of fungal NMTs using homology modeling method. The models were further refined by energy minimization and molecular dynamics simulations. The active sites of PfNMT, LmNMT and TbNMT were characterized by multiple copy simultaneous search (MCSS). MCSS functional maps reveal that PfNMT, LmNMT and TbNMT share a similar active site topology, which is defined by two hydrophobic pockets, a hydrogen-bonding (HB) pocket, a negatively-charged HB pocket and a positively-charged HB pocket. Flexible docking approaches were then employed to dock known inhibitors into the active site of PfNMT. The binding mode, structure-activity relationships and selectivity of inhibitors were investigated in detail. From the results of molecular modeling, the active site architecture and certain key residues responsible for inhibitor binding were identified, which provided insights for the design of novel inhibitors of parasitic NMTs.

Indexed as

Catalytic DomainDrug DesignModels, MolecularAcyltransferasesAmino Acid SequenceAnimalsEnzyme InhibitorsEukaryotaHydrogen BondingHydrophobic and Hydrophilic InteractionsInhibitory Concentration 50Leishmania majorMolecular Sequence DataMolecular StructureParasitesPlasmodium falciparumAcyltransferasesEnzyme Inhibitorsglycylpeptide N-tetradecanoyltransferase

Identifiers

PMID19370313
OpenAlexW2074843784

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.